1582 studies found for:    Open Studies | "Genital Diseases, Male"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Genital Diseases, Male" (1582 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Recruiting Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia;   Benign Prostatic Hyperplasia (BPH);   Prostatism;   Lower Urinary Tract Symptoms (LUTS);   Prostatic Hypertrophy;   Hyperplasia;   Male Urogenital Diseases;   Genital Diseases, Male
Intervention: Device: Embozene Microspheres
4 Not yet recruiting Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Conditions: Spinal Cord Injury;   Spinal Cord Injuries;   Trauma, Nervous System;   Wounds and Injuries;   Central Nervous System Diseases;   Nervous System Diseases;   Spinal Cord Diseases;   Gonadal Disorders;   Endocrine System Diseases;   Hypogonadism;   Genital Diseases, Male
Interventions: Drug: testosterone enanthate, finasteride;   Drug: placebo
5 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
6 Recruiting PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: [68Ga]RM2;   Procedure: PET/CT
7 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
8 Recruiting ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes
Condition: Prostate Cancer
Intervention: Drug: Indocyanine Green (ICG)
9 Not yet recruiting The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 18F-Fluoromethylcholine (18F-FCH)
10 Not yet recruiting A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
Condition: Male Infertility
Intervention: Other: no intervention
11 Not yet recruiting Safety and Efficacy Study of Type 2 Herpes Simplex Virus Therapeutic DNA Vaccine
Condition: Herpes Genitalis
Interventions: Biological: VCL-HB01;   Biological: Phosphate-buffered saline
12 Not yet recruiting A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
Condition: Infertility
Intervention: Drug: Menotrophin
13 Not yet recruiting ADT Exercise Trial and Economic Analysis
Condition: Prostate Cancer
Interventions: Behavioral: Supervised Group Exercise;   Behavioral: Home Based Exercise
14 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
15 Not yet recruiting Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer.
Interventions: Drug: Enzalutamide;   Drug: CC-115
16 Not yet recruiting Effect of Intravenous Magnesium During Robot Assisted Prostatectomy
Condition: Prostatic Neoplasms
Interventions: Drug: Magnesium Sulfate;   Drug: Normal saline
17 Recruiting CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Other: CEUS and targeted biopsies;   Other: MRI and targeted biopsies
18 Not yet recruiting Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Radiation: Stereotactic Body Radiation Therapy
19 Not yet recruiting Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
Condition: Infertility
Interventions: Drug: Decapeptyl;   Drug: hCG luteal support
20 Recruiting Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
Condition: Benign Prostate Hyperplasia
Interventions: Drug: Tamsulosin;   Drug: Solifenacin;   Drug: Solifenacin placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years